Literature DB >> 21985972

Calcium and phosphate homeostasis: concerted interplay of new regulators.

R Civitelli1, K Ziambaras.   

Abstract

Calcium and phosphate are essential to many vital physiological processes, making the maintenance of their homeostasis crucial for survival. A tightly controlled balance of calcium and phosphorus is maintained by hormonal control of transport in the intestine, bone, and kidney. The kidneys participate by modulating calcium and phosphate reabsorption from the glomerular filtrate according to the body needs. This process is mediated by ion transporters. Besides the classical endocrine factors (i.e., PTH and vitamin D metabolites), new factors have been identified that are involved in maintaining calcium and primarily phosphate balance. Fibroblast growth factor-23 (FGF23) regulates urinary phosphate excretion by interacting with FGF receptors. Klotho, a transmembrane protein, facilitates this interaction, with the result of reducing phosphate reabsorption by the kidney leading to hypophosphatemia. More recently, dental matrix protein-1, an osteocyte product, has been shown to participate in FGF23-mediated regulation of phosphorus homeostasis. Transgenic mouse models have been of great value in the elucidation of Klotho and FGF23 function. This review highlights current knowledge into calcium and phosphate homeostasis in health and disease.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21985972

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  26 in total

1.  Phosphorus Taste Involves T1R2 and T1R3.

Authors:  Michael G Tordoff
Journal:  Chem Senses       Date:  2017-06-01       Impact factor: 3.160

2.  Clinical and genetic analysis of idiopathic normophosphatemic tumoral calcinosis in 19 patients.

Authors:  Q-Y Zuo; X Cao; B-Y Liu; D Yan; Z Xin; X-H Niu; C Li; W Deng; Z-Y Dong; J-K Yang
Journal:  J Endocrinol Invest       Date:  2019-09-18       Impact factor: 4.256

Review 3.  Parathyroid hormone: anabolic and catabolic actions on the skeleton.

Authors:  Barbara C Silva; John P Bilezikian
Journal:  Curr Opin Pharmacol       Date:  2015-04-05       Impact factor: 5.547

4.  Parathyroid hormone 1 receptor is essential to induce FGF23 production and maintain systemic mineral ion homeostasis.

Authors:  Yi Fan; Ruiye Bi; Michael J Densmore; Tadatoshi Sato; Tatsuya Kobayashi; Quan Yuan; Xuedong Zhou; Reinhold G Erben; Beate Lanske
Journal:  FASEB J       Date:  2015-10-01       Impact factor: 5.191

5.  Deficiency of the calcium-sensing receptor in the kidney causes parathyroid hormone-independent hypocalciuria.

Authors:  Hakan R Toka; Khaldoun Al-Romaih; Jacob M Koshy; Salvatore DiBartolo; Claudine H Kos; Stephen J Quinn; Gary C Curhan; David B Mount; Edward M Brown; Martin R Pollak
Journal:  J Am Soc Nephrol       Date:  2012-09-20       Impact factor: 10.121

Review 6.  Interplay between CaSR and PTH1R signaling in skeletal development and osteoanabolism.

Authors:  Christian Santa Maria; Zhiqiang Cheng; Alfred Li; Jiali Wang; Dolores Shoback; Chia-Ling Tu; Wenhan Chang
Journal:  Semin Cell Dev Biol       Date:  2015-12-10       Impact factor: 7.727

Review 7.  Complicated Muscle-Bone Interactions in Children with Cerebral Palsy.

Authors:  Christopher M Modlesky; Chuan Zhang
Journal:  Curr Osteoporos Rep       Date:  2020-02       Impact factor: 5.096

8.  The impact of klotho gene polymorphisms on urinary tract stone disease.

Authors:  Abdullah Gürel; İyimser Üre; Halide Edip Temel; Oğuz Çilingir; Sema Uslu; Mehmet Fatih Celayir; Serap Aslan; Ali Barbaros Başeskioğlu
Journal:  World J Urol       Date:  2015-11-19       Impact factor: 4.226

Review 9.  Vitamin D and cardiometabolic disorders.

Authors:  Domenico Rendina; Gianpaolo De Filippo; Riccardo Muscariello; Daniela De Palma; Anna Fiengo; Francesca De Pascale; Pasquale Strazzullo
Journal:  High Blood Press Cardiovasc Prev       Date:  2014-09-09

Review 10.  Bone and skeletal muscle: neighbors with close ties.

Authors:  Douglas J DiGirolamo; Douglas P Kiel; Karyn A Esser
Journal:  J Bone Miner Res       Date:  2013-07       Impact factor: 6.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.